跳至主要内容
临床试验/NCT02235948
NCT02235948Unknown2 期

Efficacy and Safety of Folic Acid Supplementation Lowering Arsenic in a Chronic, Low-level Exposed Arsenic Population: a Randomized, Double-blind, Placebo Controlled Clinical Trial.

Wenzhou Medical University0 个研究点目标入组 450 人开始时间: 2014年7月最近更新:
适应症
干预措施

试验速览

阶段
2 期
入组人数
450
主要终点
Change of urine arsenic metabolites between baseline and week 8

研究概览

简要总结

The purpose of this study is to determine whether folic acid supplementation are effective on arsenic lowering in a chronic, low-level arsenic exposed population.

详细描述

Outcome measure:

Changes of arsenic metabolites at baseline and week 8

Methods High-performance liquid chromatography (HPLC)

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men or women more than 18 years of age and chronically exposed to arsenic (arsenic concentration of the drinking water >10ug/L);
  • Population who had no folic acid supplementation in the 2 weeks before the study;
  • Women of childbearing age agreed to use a reliable contraception method during the study;
  • Everyone volunteered to participate and signed informed consent.

排除标准

  • Pregnant or breast-feeding women;
  • Allergic to folic acid;
  • Having clearly defined allergic history;
  • Reported long-term use of folic acid and other vitamins B;
  • Having obvious signs or laboratory abnormalities which could affect the efficacy of folic acid;
  • Unsuitable to participate in the study based on the judgment of the investigators;
  • Not agree to cancel the medications which may affect serum folate concentration during the study period;
  • Subjects who plan to become pregnant during the study or move out of the area within the study period;

研究组 & 干预措施

folic acid

Experimental

folic acid supplementation placebo controlled

干预措施: folic acid supplementation (Drug)

结局指标

主要结局

Change of urine arsenic metabolites between baseline and week 8

时间窗: baseline, week 8

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Xiao Xiao

MD, PhD, professor

Wenzhou Medical University

相似试验